Zürcher Nachrichten - Who should get paid for nature's sequenced genes?

EUR -
AED 4.288053
AFN 75.89486
ALL 92.62066
AMD 426.131178
ANG 2.089769
AOA 1071.866673
ARS 1748.172706
AUD 1.639138
AWG 2.103158
AZN 1.977827
BAM 1.967749
BBD 2.351931
BDT 142.696509
BGN 1.980694
BHD 0.440231
BIF 3486.484013
BMD 1.16761
BND 1.490551
BOB 13.492644
BRL 6.045919
BSD 1.167766
BTN 111.759253
BWP 15.771772
BYN 3.551868
BYR 22885.159629
BZD 2.348511
CAD 1.612213
CDF 2653.978212
CHF 0.931397
CLF 0.027343
CLP 1076.139488
CNY 7.857725
CNH 7.857257
COP 3564.935741
CRC 522.562012
CUC 1.16761
CUP 30.94167
CVE 110.776986
CZK 24.171858
DJF 207.507835
DKK 7.475706
DOP 68.830464
DZD 155.110034
EGP 59.144823
ERN 17.514153
ETB 187.839291
FJD 2.566815
FKP 0.862158
GBP 0.858491
GEL 3.087926
GGP 0.862158
GHS 12.966304
GIP 0.862158
GMD 85.822074
GNF 10245.779009
GTQ 8.91092
GYD 244.308305
HKD 9.154292
HNL 31.385462
HRK 7.533768
HTG 152.737482
HUF 364.207969
IDR 20803.310669
ILS 3.476034
IMP 0.862158
INR 111.502394
IQD 1530.153148
IRR 1604996.960374
ISK 142.191803
JEP 0.862158
JMD 184.52048
JOD 0.82787
JPY 184.837394
KES 151.135367
KGS 102.107534
KHR 4722.983654
KMF 492.731757
KPW 1050.84951
KRW 1620.362388
KWD 0.359916
KYD 0.973109
KZT 539.393861
LAK 26301.58643
LBP 104559.491772
LKR 386.466777
LRD 211.512574
LSL 18.90372
LTL 3.447649
LVL 0.706276
LYD 7.414139
MAD 10.797184
MDL 20.138288
MGA 5020.72372
MKD 61.519741
MMK 2451.10096
MNT 4200.070013
MOP 9.431048
MRU 46.832636
MUR 54.853835
MVR 18.04
MWK 2026.971232
MXN 19.794356
MYR 4.720762
MZN 74.604483
NAD 18.796701
NGN 1576.577256
NIO 42.816975
NOK 10.893564
NPR 178.818858
NZD 1.967248
OMR 0.448964
PAB 1.167766
PEN 3.928428
PGK 5.156458
PHP 72.095841
PKR 324.11421
PLN 4.319767
PYG 7024.656458
QAR 4.254721
RON 5.24631
RSD 117.291138
RUB 98.083935
RWF 1712.884142
SAR 4.385776
SBD 9.378546
SCR 16.604807
SDG 702.30436
SEK 11.022543
SGD 1.484546
SHP 0.865043
SLE 28.733085
SLL 24484.200875
SOS 667.295778
SRD 44.067961
STD 24167.173437
STN 24.957668
SVC 10.217916
SYP 15181.267518
SZL 18.777984
THB 38.374694
TJS 10.772283
TMT 4.086636
TND 3.382858
TOP 2.811325
TRY 55.988658
TTD 7.920929
TWD 37.164798
TZS 3091.511839
UAH 52.211075
UGX 4355.354158
USD 1.16761
UYU 46.804213
UZS 13798.23957
VES 906.584331
VND 30568.618452
VUV 138.029605
WST 3.17111
XAF 659.964563
XAG 0.0174
XAU 0.000259
XCD 3.155525
XCG 2.104553
XDR 0.825561
XOF 659.700147
XPF 119.331742
YER 276.811225
ZAR 18.797677
ZMK 10509.895564
ZMW 21.865307
ZWL 375.970003
  • CMSC

    0.0580

    21.298

    +0.27%

  • BCC

    2.9500

    83.13

    +3.55%

  • JRI

    -0.0600

    12.38

    -0.48%

  • BCE

    0.3400

    23.7

    +1.43%

  • AZN

    4.8500

    164.95

    +2.94%

  • BTI

    -0.4000

    55.98

    -0.71%

  • GSK

    1.7300

    52.88

    +3.27%

  • CMSD

    0.0600

    21.15

    +0.28%

  • RIO

    3.7500

    100.44

    +3.73%

  • NGG

    -1.4900

    80.66

    -1.85%

  • RBGPF

    0.3500

    69.35

    +0.5%

  • RYCEF

    0.0200

    20.83

    +0.1%

  • VOD

    0.0400

    16.17

    +0.25%

  • BP

    0.3200

    43.73

    +0.73%

  • RELX

    0.5900

    35.1

    +1.68%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: Menahem KAHANA - AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

N.Zaugg--NZN